JP2005516004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005516004A5 JP2005516004A5 JP2003550776A JP2003550776A JP2005516004A5 JP 2005516004 A5 JP2005516004 A5 JP 2005516004A5 JP 2003550776 A JP2003550776 A JP 2003550776A JP 2003550776 A JP2003550776 A JP 2003550776A JP 2005516004 A5 JP2005516004 A5 JP 2005516004A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- receptor
- affinity
- composition according
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33673201P | 2001-12-07 | 2001-12-07 | |
| PCT/US2002/039310 WO2003049727A1 (en) | 2001-12-07 | 2002-12-09 | Treatment of neoplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005516004A JP2005516004A (ja) | 2005-06-02 |
| JP2005516004A5 true JP2005516004A5 (https=) | 2006-02-02 |
Family
ID=23317407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003550776A Pending JP2005516004A (ja) | 2001-12-07 | 2002-12-09 | 新形成の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040259936A1 (https=) |
| EP (1) | EP1461027A4 (https=) |
| JP (1) | JP2005516004A (https=) |
| AU (1) | AU2002357114B2 (https=) |
| CA (1) | CA2468794A1 (https=) |
| WO (1) | WO2003049727A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7528165B2 (en) * | 2001-12-13 | 2009-05-05 | National Health Research Institutes | Indole compounds |
| US7632955B2 (en) * | 2001-12-13 | 2009-12-15 | National Health Research Institutes | Indole compounds |
| WO2005023232A2 (en) * | 2003-09-04 | 2005-03-17 | Affibody Ab | Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| EP1736775A4 (en) * | 2004-04-12 | 2008-03-12 | Takeda Pharmaceutical | NEW LIGAND OF A G-PROTEIN-COUPLED RECEPTOR PROTEIN AND USE THEREOF |
| TWI360539B (en) | 2004-10-28 | 2012-03-21 | Shionogi & Co | 3-carbamoyl-2-pyridone derivatives |
| US7456289B2 (en) * | 2004-12-31 | 2008-11-25 | National Health Research Institutes | Anti-tumor compounds |
| EP2091926B1 (en) * | 2006-11-13 | 2015-10-21 | Novartis AG | Substituted pyrazole and triazole compounds as ksp inhibitors |
| IN2012DN02474A (https=) | 2009-08-28 | 2015-08-21 | Arena Pharm Inc | |
| KR20130020881A (ko) | 2010-02-08 | 2013-03-04 | 알러간, 인코포레이티드 | 칸나비노이드-2 효능제로서 유용한 피리다진 유도체 |
| AU2012222149B2 (en) | 2011-02-25 | 2017-06-29 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| EP2678330A1 (en) | 2011-02-25 | 2014-01-01 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators) |
| US9597340B2 (en) | 2011-02-25 | 2017-03-21 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| WO2016085941A1 (en) | 2014-11-25 | 2016-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of cannabinoid receptor modulators |
| CA3140290A1 (en) * | 2019-05-16 | 2020-11-19 | Technion Research & Development Foundation Limited | Cannabinoids and uses thereof |
| CN115282279B (zh) * | 2022-08-08 | 2024-03-12 | 暨南大学附属第一医院（广州华侨医院） | CNR2通过介导DCs成熟及功能作为脓毒症急性肺损伤治疗靶点的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1271266B (it) * | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
| FR2735774B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
| ATE277921T1 (de) * | 1998-05-04 | 2004-10-15 | Univ Connecticut | Selektiv auf den cb2-rezeptor wirkende cannabinoide |
| CA2387892A1 (en) * | 1999-10-18 | 2001-04-26 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
| FR2800372B1 (fr) * | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
| WO2001058869A2 (en) * | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
-
2002
- 2002-12-09 EP EP02804754A patent/EP1461027A4/en not_active Withdrawn
- 2002-12-09 CA CA002468794A patent/CA2468794A1/en not_active Abandoned
- 2002-12-09 JP JP2003550776A patent/JP2005516004A/ja active Pending
- 2002-12-09 US US10/497,911 patent/US20040259936A1/en not_active Abandoned
- 2002-12-09 AU AU2002357114A patent/AU2002357114B2/en not_active Ceased
- 2002-12-09 WO PCT/US2002/039310 patent/WO2003049727A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005516004A5 (https=) | ||
| BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
| JP2005524658A5 (https=) | ||
| WO2001035941A8 (en) | Novel composition based on a thiazolidinedione and metformin and use | |
| PT1506185E (pt) | Compostos novos e sua utilizacao | |
| JP2002506084A5 (https=) | ||
| WO2001028498A3 (en) | Retro-anandamides, high affinity and stability cannabinoid receptor ligands | |
| MA27206A1 (fr) | Azetidinones substituees par des groupements acides, procede pour leur preparation, medicaments contenant lesdits composes et utilisation de ceux-ci. | |
| ATE399787T1 (de) | Metallkomplexe der gruppe 4 des pse, die 4-aryl substituierte, tricyclische indenylderivate enthalten | |
| WO2005041747A3 (en) | Stealthy nano agents | |
| CA2327784A1 (en) | Triazolones with a neuroprotective action | |
| JP2005525089A5 (https=) | ||
| CA2272014A1 (en) | N-aryl/heteroaryl-substituted heterocycles | |
| CA2160101A1 (en) | Metallocene compound | |
| DE50311275D1 (de) | Blutstillungsmittel enthaltend polyvinylalkohol und seine bereitstellung für die medizin | |
| AU2003224744A8 (en) | Fuel cell catalyst containing pt and rh and at least one of w, sn and cu and optionally mo. | |
| JP2002277470A5 (https=) | ||
| JP2006527741A5 (https=) | ||
| JP2004531567A5 (https=) | ||
| ATE308551T1 (de) | Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten | |
| Levison | Who Lost the Working Class?(Book Review) | |
| 瞿金平 et al. | Research on elastic behaviors of LDPE melt during capillary dynamic extrusion | |
| PT1105503E (pt) | Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada | |
| RU2003102902A (ru) | Спермицидная активность этония | |
| CA2379557A1 (en) | Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |